News Articles for CSL

WA's medical sector is anxiously awaiting fallout from the US's pharma tariffs, although impending changes could assuage US concerns.

Mining giants BHP and Rio Tinto are bracing for a new 50 per cent tariff on copper imports.

BCI Minerals has entered into a 21-year agreement with CSL Australia, worth $598 million.

Blood products and vaccines supplier CSL has reported a six per cent fall in annual profit and is tipping a slightly better earnings performance in 2022/23.

Prime Minister Scott Morrison says supplies are not yet sufficient to bring large numbers of pharmacies into the COVID-19 vaccination program.

Scott Morrison has defended Australia's vaccine rollout while hinting the population could yet be fully inoculated against COVID-19 by the end of this year.

Australia has hit the half a million milestone for COVID-19 vaccinations but is way short of the four million jabs the government predicted just a few months ago.

Australia's vaccine rollout will ramp up quickly over the next month as hundreds of thousands of doses make their way across the country.

Perth-based HealthEngine has been chosen by the federal government to build its COVID-19 vaccination booking platform.

Australians have been told to still expect their first dose of a coronavirus vaccine by October, with the federal government sticking by its time frame despite initial delays in the rollout.

Medical experts believe the federal government's coronavirus vaccination target will be hard to achieve unless jab rates are dramatically ramped up.

Biotech giant CSL says it has accelerated the manufacture of the AstraZeneca COVID-19 vaccine with the first doses planned for release in late March.

Almost $2 billion will be spent equipping hospitals and other health centres to administer coronavirus vaccines.

As the federal government readies its vaccine rollout, can WA manage the health and economic risks of a second wave of coronavirus?

ASX investors had a sixth consecutive week of gains, but the benefit was minor, as an analyst wondered whether bank shares had become too expensive.

A new flu vaccine manufacturing plant will be built in Melbourne to guard against future pandemics and provide antivenoms for some of Australia's most deadly creatures.

Australia will focus on bringing a growing list of people stranded overseas home before considering allowing international students into the country again.

Production of coronavirus vaccinations has begun in Victoria as national case numbers continue to fall.

Manufacturing of the first coronavirus vaccine for Australians will start in Melbourne next week.

Australia is on track to receive its first batch of coronavirus vaccinations early next year.

Every Australian could receive a free coronavirus vaccination early next year, if a promising trial proves successful.

The wild ride for the Australian share market has continued with a 330-point swing that turned its early strong gains into an afternoon loss.

The Australian share market has rallied hard in its final minutes for its best day ever after Prime Minister Scott Morrison announced the government's fiscal stimulus measures.

The Australian share market has shaken off a weak lead from Wall Street to rise early as government prepares to announce further economic support measures for businesses amid the COVID-19 pandemic.

CSL's full-year profit has risen 11 per cent to $US1.92 billion ($A2.82 billion), driven by disease diagnosis and global demand for its immunoglobulin portfolio.

Australia's most generous corporate donors have been named in the inaugural GivingLarge report, with Wesfarmers and CSL receiving top billing.

The federal government has watered down planned changes to the research and development tax incentive scheme, which industry players say will improve its impact on productivity.

The $1.4 billion joint bid by Baosteel and Aurizon for control of Perth-based Aquila Resources marks a new wave of Chinese investment interest in WA's iron ore.

Perth-based burns treatment company Clinical Cell Culture Ltd has entered into a supply agreement with pharmaceutical company CSL Ltd for the supply of Trypsin, a key component of the Company's ReCell tissue harvesting device.